首页 > 产品目录 > 免疫学 > 抗体 > Anti-BRCA2 antibody

Anti-BRCA2 antibody

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
50ug
- +
产品详情
  • 产品名称

    Anti-BRCA2抗体
    参阅全部 BRCA2 一抗

  • 描述

    兔多克隆抗体to BRCA2

  • 宿主

    Rabbit

  • 经测试应用

    适用于: WBIPmore details

  • 种属反应性

    与反应: Human
    预测可用于: Chimpanzee, Gorilla

  • 免疫原

    Synthetic peptide corresponding to Human BRCA2.

  • 阳性对照

    • IP: HEK-293T cell lysate. WB: HEK293T, OVCAR-3, Hep-G2, K-562, Jurkat, HeLa, U2OS, and MCF-7 whole cell lysates.

  • 常规说明


    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

  • 存储溶液

    pH: 7
    Preservative: 0.09% Sodium azide
    Constituents: 0.021% PBS, 1.764% Sodium citrate, 1.815% Tris

  • 纯度

    Immunogen affinity purified

  • 纯化说明

    Antibodies were affinity purified using the peptide immobilized on solid support. Antibody concentration was determined by extinction coefficient: absorbance at 280 nmof 1.4 equals 1.0 mg of IgG.

  • 克隆

    多克隆

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab9143于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
WB(1)

1/2000 - 1/10000. Predicted molecular weight: 384 kDa.

IP

Use a concentration of 2 - 10 µg/ml.

  • 数据库链接

  • 别名

    • BRCA2, DNA repair associated antibody

    • BRCA2_HUMAN antibody

    • BRCC 2 antibody

    • BRCC2 antibody

    • Breast and ovarian cancer susceptibility gene early onset antibody

    • breast and ovarian cancer susceptibility protein 2 antibody

    • Breast cancer 2 early onset antibody

    • Breast Cancer 2 tumor suppressor antibody

    • Breast cancer susceptibility protein BRCA2 antibody

    • Breast cancer type 2 susceptibility protein antibody

    • BROVCA2 antibody

    • FACD antibody

    • FAD 1 antibody

    • FAD antibody

    • FAD1 antibody

    • FANCB antibody

    • FANCD 1 antibody

    • FANCD antibody

    • FANCD1 antibody

    • FANCD1 gene antibody

    • Fanconi anemia complementation group D1 antibody

    • Fanconi anemia group D1 protein antibody

    • GLM3 antibody

    • mutant BRCA2 antibody

    • OTTHUMP00000018803 antibody

    • OTTHUMP00000042401 antibody

    • PNCA2 antibody

    • XRCC11 antibody

    • BRCA 2 antibody

    • BRCA1/BRCA2 containing complex subunit 2 antibody

    • Brca2 antibody

  • Immunoprecipitation - Anti-BRCA2 antibody (ab9143)

    Immunoprecipitation - Anti-BRCA2 antibody (ab9143)

    BRCA2 was immunoprecipitated from HEK293T whole cell lysate (1 mg per IP reaction, 20% loaded) with ab9143 at 6 µg per reaction. Western blot was performed on the immunoprecipitate using ab9143 at 0.01 µg/mL.

    Lane 1: ab9143 IP in HEK293T whole cell lysate.

    Lane 2: ab9143 IP in HEK293T whole cell lysate.

    Lane 3: Control IgG in HEK293T whole cell lysate.

    Detection: Chemiluminescence with an exposure time of 30 seconds

  • Western blot - Anti-BRCA2 antibody (ab9143)

    Western blot - Anti-BRCA2 antibody (ab9143)

    All lanes : Anti-BRCA2 antibody (ab9143) at 0.1 µg/ml

    Lane 1 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
    Lane 2 : OVCAR-3 (human ovary epithelial adenocarcinoma cell line) whole cell lysate
    Lane 3 : HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate
    Lane 4 : K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate
    Lane 5 : Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate
    Lane 6 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
    Lane 7 : U-2 OS (human bone osteosarcoma epithelial cell line) whole cell lysate
    Lane 8 : MCF7 (human breast adenocarcinoma cell line) whole cell lysate

    Lysates/proteins at 50 µg per lane.

    Predicted band size: 384 kDa


    Exposure time: 3 minutes